Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT03338387
PHASE2

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

Sponsor: Charles University, Czech Republic

View on ClinicalTrials.gov

Summary

This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.

Official title: Acipimox Administration Together With Short-Term Exercise Exerts A Co-Feedback of Growth Hormone, Pancreatic Polypeptide, Peptide YY and Leptin on Ghrelin in Young Bulimic Czech Women: A Randomized Study

Key Details

Gender

FEMALE

Age Range

18 Years - 30 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2003-05-06

Completion Date

2026-12-20

Last Updated

2025-02-19

Healthy Volunteers

Yes

Interventions

DRUG

Acipimox

Acipimox

DRUG

Placebo

Placebo Other Names: Placebo (for Olbetam)